Bath emollients have ‘no benefit beyond standard eczema care for children’

Bath emollients have ‘no benefit beyond standard eczema care for children’

May 9 2018 A study has found no evidence of clinical benefit from including bath emollients in...

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

April 16 2018 Honey appears likely to help children’s cough more than diphenhydramine, a...

OTC Viagra Connect availability to widen following launch via Boots

OTC Viagra Connect availability to widen following launch via Boots

April 11 2018 Viagra Connect should be available from most pharmacies at the end of this week,...

MHRA issues warning over flammability of headlice treatments

MHRA issues warning over flammability of headlice treatments

March 9 2018 Pharmacists have been asked to tell customers about the risk of fire when discussing...

OTC industry proposes maximum level for vitamin D in food supplements

OTC industry proposes maximum level for vitamin D in food supplements

March 6 2018 Food supplement manufacturers are proposing to set the maximum dose of vitamin D at...

  • Bath emollients have ‘no benefit beyond standard eczema care for children’

    Bath emollients have ‘no benefit beyond standard eczema care for children’

    Wednesday, 09 May 2018 15:28
  • Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Monday, 16 April 2018 09:13
  • OTC Viagra Connect availability to widen following launch via Boots

    OTC Viagra Connect availability to widen following launch via Boots

    Wednesday, 11 April 2018 12:52
  • MHRA issues warning over flammability of headlice treatments

    MHRA issues warning over flammability of headlice treatments

    Friday, 09 March 2018 16:15
  • OTC industry proposes maximum level for vitamin D in food supplements

    OTC industry proposes maximum level for vitamin D in food supplements

    Tuesday, 06 March 2018 12:24

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a bmj logo cbAugust 25 2017

Using dietary supplements containing anti-oxidants, zinc and copper can help delay progression of macular degeneration and could be a cost-effective approach to eye care.

With the supplements being relatively inexpensive compared to drugs used to treat disorders such as ‘wet’ age-related macular degeneration, the supplements should be available on the NHS, the researchers have also proposed.

The findings are made in the British Journal of Ophthalmology. Researchers from London and the US evaluated the cost-effectiveness of certain supplements in patients with either bilateral intermediate age-related macular degeneration or unilateral neovascular age-related macular degeneration AMD (nAMD). Quality-adjusted life years (QALYs) and healthcare costs were the main outcome measures when compared to no intervention.

There was an improvement in both QALY with supplements and cost savings over the lifetime of the patient. Depending on the type of combination supplement given, they can be “both cost saving and more effective than no supplement use and should therefore be considered in public health policy.”

Reporting on the study, the BMJ Newsroom said two formulations were trialled. “Formulation 1 contained high doses of vitamins C and E, beta carotene, zinc and copper; in formulation 2, beta carotene was replaced with lutein and zeaxanthin, but the other constituents remained the same. Both formulations are commercially available.

“Their analysis showed that both formulations are cost effective for treating patients with early stage ‘wet’ AMD, but they were more cost effective for those with the condition in just one eye.”

Links:
BMJ Newsroom announcement                  
AY Lee et al. ‘Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data’. British Journal of Ophthalmology. August 2017                  

 

OTC News

May 23 2018 The Court of Appeal has commenced hearing a case around the Government’s cut in pharmacy funding and other changes to community pharmacy introduced in 2016.
May 21 2018  NHS England and Capita’s handling of primary care support services has been criticised in an official report. The National Audit Office has published a review saying that “NHS England and...